Targocid is a brand name medication that contains the active substance teicoplanin. It is an antibiotic drug used to treat certain bacterial infections. Teicoplanin belongs to the glycopeptide class of antibiotics and is primarily used to fight infections caused by Gram-positive bacteria.
Targocid works by inhibiting the growth and replication of susceptible bacteria, thereby preventing the spread of the infection. It does this by interfering with the synthesis of the bacterial cell wall, which is crucial for their survival and proliferation.
This medication is commonly prescribed to treat severe or deep-seated infections, such as infections of the bones and joints, complicated skin and soft tissue infections, and respiratory tract infections caused by methicillin-resistant Staphylococcus aureus (MRSA) bacteria. It may also be used as a prophylactic treatment for certain surgical procedures to prevent postoperative infections.
Targocid is usually administered through an intravenous (IV) infusion or injection by a healthcare professional. The dosage and duration of treatment may vary depending on the type and severity of the infection, as well as the patient's individual response to the medication.
As with any medication, Targocid may cause side effects, such as diarrhea, nausea, vomiting, rash, or allergic reactions. It is important to follow the prescribed dosage and complete the full course of treatment to ensure effective eradication of the infection.
